References
Petrak RM, Pottage JC Jr, Levin S. Invasive External Otitis caused by Aspergillus fumigatus in an Immunocompromised Patient. Article
Bryce GE, Phillips P, Lepawsky M, Gribble MJ. Invasive Aspergillus tympanomastoiditis in an immunocompetent patient. J Otolaryngol. 1997 Aug;26(4):266-9 PubMed
Bickley LS, Betts RF, Parkins CW. Atypical invasive external otitis from Aspergillus. Arch Otolaryngol Head Neck Surg. 1988 Sep;114(9):1024-8 PubMed
Cunningham M, Yu VL, Turner J, Curtin H. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg. 1988 May;114(5):554-6 Article
Stanley RJ, McCaffrey TV, Weiland LH. Fungal mastoiditis in the immunocompromised host. Arch Otolaryngol Head Neck Surg. 1988 Feb;114(2):198-9 PubMed
Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med. 1989 Jun;86(6 Pt 2):791-800 Article
Phillips P, Bryce G, Shepherd J, Mintz D. Invasive external otitis caused by Aspergillus. Rev Infect Dis. 1990 Mar-Apr;12(2):277-81 Article
Lamprecht J, Kühn AG, Sauer S. [Aspergillus mastoiditis in infected granulomatosis–a case report]. Laryngorhinootologie. 1990 Jun;69(6):341-4 PubMed
Menachof MR, Jackler RK. Otogenic skull base osteomyelitis caused by invasive fungal infection. Otolaryngol Head Neck Surg. 1990 Mar;102(3):285-9 Article
Reiss P, Hadderingh R, Schot LJ, Danner SA. Invasive external otitis caused by Aspergillus fumigatus in two patients with AIDS. AIDS. 1991 May;5(5):605-6 Article
Strauss M, Fine E. Aspergillus otomastoiditis in acquired immunodeficiency syndrome. Am J Otol. 1991 Jan;12(1):49-53 Article
Kawamura T, Ikeda H, Nakasato N, Ogawa A, Yoshimoto T. [A case of intracerebral epidermoid associated with aspergillosis]. No Shinkei Geka. 1992 Apr;20(4):463-7 PubMed
Murai H, Kira J, Kobayashi T, Goto I, Inoue H, Hasuo K. Hypertrophic cranial pachymeningitis due to Aspergillus flavus. Clin Neurol Neurosurg. 1992;94(3):247-50 Article
Dinçer AD, Tekeli A, Oztürk S, Turgut S. [Microorganisms isolated from chronic suppurative otitis media and their antimicrobial sensitivities]. Mikrobiyol Bul. 1992 Apr;26(2):131-8 PubMed
Comacchio F, D’Eredità R, Bison E, Chierichetti F, Ferlin G, Marchiori C. [Value of TC99m-Nanocolloid spect in diagnosis and follow-up of necrotizing external otitis]. Acta Otorhinolaryngol Ital. 1993 Nov-Dec;13(6):517-24 PubMed
Hall PJ, Farrior JB. Aspergillus mastoiditis. Otolaryngol Head Neck Surg. 1993 Feb;108(2):167-70 Article
Hanna E, Hughes G, Eliachar I, Wanamaker J, Tomford W. Fungal osteomyelitis of the temporal bone: a review of reported cases. Ear Nose Throat J. 1993 Aug;72(8):532, 537-41 Article
Kim DG, Hong SC, Kim HJ, Chi JG, Han MH, Choi KS, Han DH. Cerebral aspergillosis in immunologically competent patients. Surg Neurol. 1993 Oct;40(4):326-31 Article
Landry MM, Parkins CW. Calcium oxalate crystal deposition in necrotizing otomycosis caused by Aspergillus niger. Mod Pathol. 1993 Jul;6(4):493-6 PubMed
Hanna, E, Hughes, G, Eliachar I, Wanamaker J, Tomford W. Fungal osteomyelitis of the temporal bone: A review of reported cases. ENT J 1993; 72:532-541
Gordon G, Giddings NA. Invasive otitis externa due to Aspergillus species: case report and review. Clin Infect Dis. 1994 Nov;19(5):866-70 Article
Dalle JH, Dollfus C, Leverger G, Landman-Parker J, Tabone MD, Adam M, Courpotin C, Lasfargues G. [Hemophagocytic syndrome in children infected by HIV. Apropos of 3 cases]. Arch Pediatr. 1995 May;2(5):442-6 Article
Harley WB, Dummer JS, Anderson TL, Goodman S. Malignant external otitis due to Aspergillus flavus with fulminant dissemination to the lungs. Clin Infect Dis. 1995 Apr;20(4):1052-4 Article
Tiwari S, Singh SM, Jain S. Chronic bilateral suppurative otitis media caused by Aspergillus terreus. Mycoses. 1995 Jul-Aug;38(7-8):297-300 Article
Ibekwe AO, al Shareef Z, Benayam A. Anaerobes and fungi in chronic suppurative otitis media. Ann Otol Rhinol Laryngol. 1997 Aug;106(8):649-52 Article
Pak MW, Soo G, van Hasselt CA. Flourishing otomycosis. Ear Nose Throat J. 1997 Jan;76(1):10 PubMed
Martínez-Berriotxoa A, Montejo M, Aguirrebengoa K, González de Zárate P, Aguirre C. [Otomastoiditis caused by Aspergillus in AIDS]. Enferm Infecc Microbiol Clin. 1997 Apr;15(4):200-2 PubMed
Kountakis SE, Kemper JV Jr, Chang CY, DiMaio DJ, Stiernberg CM. Osteomyelitis of the base of the skull secondary to Aspergillus. Am J Otolaryngol. 1997 Jan-Feb;18(1):19-22 Article
Yates PD, Upile T, Axon PR, de Carpentier J. Aspergillus mastoiditis in a patient with acquired immunodeficiency syndrome. J Laryngol Otol. 1997 Jun;111(6):560-1 Article
Ress BD, Luntz M, Telischi FF, Balkany TJ, Whiteman ML. Necrotizing external otitis in patients with AIDS. Laryngoscope. 1997 Apr;107(4):456-60 Article
Muñoz A, Martínez-Chamorro E. Necrotizing external otitis caused by Aspergillus fumigatus: computed tomography and high resolution magnetic resonance imaging in an AIDS patient. J Laryngol Otol. 1998 Jan;112(1):98-102 Article
Chen D, Lalwani AK, House JW, Choo D. Aspergillus mastoiditis in acquired immunodeficiency syndrome. Am J Otol. 1999 Sep;20(5):561-7 Article
Slack CL, Watson DW, Abzug MJ, Shaw C, Chan KH. Fungal mastoiditis in immunocompromised children. Arch Otolaryngol Head Neck Surg. 1999 Jan;125(1):73-5 PubMed
Lizarralde E, Teira R, Zubero Z, Baraia-Etxaburo J, Fiz J, Santamaría JM. [Otomastoiditis by Aspergillus fumigatus in a patient with AIDS]. Acta Otorrinolaringol Esp. 1999 Apr;50(3):247-8 PubMed
Geerlings SE, Hoepelman AL. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999;26:259–65.
Attallah MS. Microbiology of chronic suppurative otitis media with cholesteatoma. Saudi Med J. 2000 Oct;21(10):924-7 PubMed
Khanna V, Chander J, Nagarkar NM, Dass A. Clinicomicrobiologic evaluation of active tubotympanic type chronic suppurative otitis media. J Otolaryngol. 2000 Jun;29(3):148-53 PubMed
Ohki M, Ito K, Ishimoto S. Fungal mastoiditis in an immunocompetent adult. Eur Arch Otorhinolaryngol. 2001 Mar;258(3):106-8 Article
Finer G, Greenberg D, Leibovitz E, Leiberman A, Shelef I, Kapelushnik J. Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient. Scand J Infect Dis. 2002;34(3):227-9 Article
Shelton JC, Antonelli PJ, Hackett R. Skull base fungal osteomyelitis in an immunocompetent host. Otolaryngol Head Neck Surg. 2002 Jan;126(1):76-8 PubMed
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408–15.
Bellini C, Antonini P, Ermanni S, Dolina M, Passega E, Bernasconi E. Malignant otitis externa due to Aspergillus niger. Scand J Infect Dis. 2003;35(4):284-8 Article
Rubin Grandis J, Branstetter BF, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis 2004;4:34–9.
Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004617 Article
Narozny W, Kuczkowski J, Stankiewicz C, Kot J, Mikaszewski B, Przewozny T. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol. 2006 Jul;263(7):680-4 Article
Stodulski D, Kowalska B, Stankiewicz C. Otogenic skull base osteomyelitis caused by invasive infection. Eur Arch Otorhinolaryngol 2006;263:1070–6.
Lewis RE, Wiederhold NP, Klepser ME. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Antimicrob Agents Chemother 2005;49:945–51
Ling SS, Sader C. Fungal malignant otitis externa treated with hyperbaric oxygen. Int J Infect Dis. 2008 Sep;12(5):550-2 Article
Denes E, Boumediene A, Durox H, Oksman A, Saint-Marcoux F, Darde ML et al. Voriconazole concentrations in synovial fluid and bone tissues. J Antimicrob Chemother 2007;59: 818–19.
Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology. 2007;153:1677–92.
Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin N Am 2008;41:537–9.
Mani R, Belcadhi M, Ben Said M, Bouzouita K. Aspergillus mastoiditis with intact tympanic membrane in immunocompetent host. B-ENT. 2008;4(1):39-43 PubMed
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of Aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46: 327–60.
Balajee SA, Borman AM, Brandt ME, et al. Sequence-based identifcation of Aspergillus, Fusarium and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol. 2009;47:877–84
Parize P, Chandesris MO, Lanternier F, Poirée S, Viard JP, Bienvenu B, Mimoun M, Méchai F, Mamzer MF, Herman P, Bougnoux ME, Lecuit M, Lortholary O. Antifungal Therapy of Aspergillus Invasive Otitis Externa: Efficacy of Voriconazole and Review. Antimicrob Agents Chemother. 2009 Mar;53(3):1048-53 Article
van Tol A, van Rijswijk J. Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient. Eur Arch Otorhinolaryngol. 2009 Oct;266(10):1655-7. doi: 10.1007/s00405-008-0877-4. Epub 2008 Dec 4 Article
Pasqualotto AC. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus. Med Mycol 2009;47 (Suppl. 1):S261–70.
Krishnan S, Manavathu EK, Chandrasekar PH. Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses 2009;52:206–22.
Vennewald I, Klemm E. Otomycosis. Diagnosis and treatment. Clin Dermatol 2010;28:202–11.
References:
Case histories: